<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-vaccines-07-00070">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>E</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Meraner</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Perreira</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Aker</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>McDougall</surname>
    <given-names>W.M.</given-names>
   </name>
   <name>
    <surname>Zhuge</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>G.C.</given-names>
   </name>
   <name>
    <surname>Gerstein</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Caposio</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2019</year>
  <volume>116</volume>
  <fpage>7043</fpage>
  <lpage>7052</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1814850116</pub-id>
  <?supplied-pmid 30894498?>
  <pub-id pub-id-type="pmid">30894498</pub-id>
 </element-citation>
</ref>
